Due to the emergence of leptin replacement therapy, which has primarily been utilized for the treatment of lipodystrophy, [49] future studies targeting this adipokine pathway in individuals with reduced muscle loss may be an important area of research. The gene discussed is LEP; the disease is lipodystrophy.